azacitidine has been researched along with Carcinoma, Pancreatic Ductal in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (47.06) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Diamond, DJ; Ebelt, ND; Johnson, BL; Manuel, ER; Zuniga, E | 1 |
| Gailhouste, L; Hatada, I; Liew, LC; Nakagama, H; Ochiya, T | 1 |
| Bushell, MD; Godfrey, JD; Morton, JP; Sansom, OJ; Wilczynska, A | 1 |
| Ahuja, N; Cai, Y; Hu, Y; Karunasena, E; Keer, H; Lerner, L; Morreale, M; Saggi, S; Sen, R; Thakar, M; Ying Lin, W | 1 |
| Barthet, M; Bories, E; Calvo, E; Duconseil, P; Dusetti, N; Ewald, J; Garcia, S; Gasmi, M; Gayet, O; Gilabert, M; Giovannini, M; Goncalves, A; Iovanna, J; Loncle, C; Lopez, MB; Moutardier, V; Ouaissi, M; Poizat, F; Raoul, JL; Secq, V; Turrini, O; Viens, P | 1 |
| Cheng, XB; Hirata, K; Koga, A; Kohi, S; Sato, N | 1 |
| Han, ZB; Hao, J; Huang, C; Jia, Z; Jiang, W; Li, Y; Ren, H; Sun, Y; Wang, H; Wang, X; Xie, K; Yang, S; Zhao, T; Zheng, C | 1 |
| Ammerpohl, O; Fölsch, UR; Kalthoff, H; Koch, D; Müerköster, SS; Schäfer, H; Sipos, B; Tsao, MS; Werbing, V | 1 |
| Cecconi, D; Dalla Pozza, E; Donadelli, M; Palmieri, M; Righetti, PG; Rinalducci, S; Scarpa, A; Scupoli, MT; Zolla, L | 1 |
| Chen, J; Cui, Q; Lu, Z; Zhao, L | 1 |
| Brooks, J; Cullo, A; Davies, J; Gonda, T; Hirsch, S; Kim, S; Ludwig, T; Olive, K; Quante, M; Salas, M; Shakya, R; Szabolcs, M; Tycko, B; Wang, TC | 1 |
| Biallek, M; Jonat, W; Klöppel, G; Lüttges, J; Maass, N; Morohoshi, T; Mundhenke, C; Nagasaki, K; Ohike, N; Zhang, M | 1 |
| Astner, H; Cecconi, D; Donadelli, M; Hamdan, M; Missiaglia, E; Palmieri, M; Righetti, PG; Scarpa, A | 1 |
| Eshleman, JR; Fukushima, N; Goggins, M; Iacobuzio-Donahue, CA; Miyagi, Y; Parker, AR; Sato, N | 1 |
| Furukawa, T; Horii, A; Kanai, N; Sunamura, M; Xu, S | 1 |
| Abe, T; Fukushima, N; Goggins, M; Matsubayashi, H; Sato, N | 1 |
| Jiang, P; Mouri, H; Ohtsubo, K; Okada, G; Sawabu, N; Tsuchiyama, T; Watanabe, H; Yao, F | 1 |
17 other study(ies) available for azacitidine and Carcinoma, Pancreatic Ductal
| Article | Year |
|---|---|
5-Azacytidine Potentiates Anti-tumor Immunity in a Model of Pancreatic Ductal Adenocarcinoma.
Topics: Animals; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Azacitidine; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Disease Models, Animal; DNA Transposable Elements; Humans; Mice; Mice, Inbred C57BL; Pancreatic Neoplasms | 2020 |
Epigenetic reprogramming using 5-azacytidine promotes an anti-cancer response in pancreatic adenocarcinoma cells.
Topics: Animals; Azacitidine; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Pancreatic Neoplasms; Xenograft Model Antitumor Assays | 2018 |
MiR-142-3p is downregulated in aggressive p53 mutant mouse models of pancreatic ductal adenocarcinoma by hypermethylation of its locus.
Topics: Animals; Azacitidine; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; CpG Islands; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; Down-Regulation; Gene Expression Regulation, Neoplastic; Genetic Loci; Humans; Mice; MicroRNAs; Mutation; Neoplasm Invasiveness; Pancreatic Neoplasms; RNA, Messenger; Survival Analysis; Tumor Suppressor Protein p53 | 2018 |
A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent.
Topics: Antineoplastic Agents; Azacitidine; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Survival; DNA (Cytosine-5-)-Methyltransferase 1; Epigenesis, Genetic; Humans; Irinotecan; Pancreas; Pancreatic Neoplasms; Topoisomerase I Inhibitors | 2018 |
A subgroup of pancreatic adenocarcinoma is sensitive to the 5-aza-dC DNA methyltransferase inhibitor.
Topics: Animals; Azacitidine; Carcinoma, Pancreatic Ductal; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methyltransferase 3A; DNA Methyltransferase 3B; Enzyme Inhibitors; Humans; Mice; Mice, Nude; Pancreatic Neoplasms; Transcriptome; Xenograft Model Antitumor Assays | 2015 |
Increased Expression of HYAL1 in Pancreatic Ductal Adenocarcinoma.
Topics: Azacitidine; Carcinoma, Pancreatic Ductal; Decitabine; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Pancreatic Neoplasms | 2016 |
ESE3 Inhibits Pancreatic Cancer Metastasis by Upregulating E-Cadherin.
Topics: Animals; Antigens, CD; Azacitidine; Cadherins; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Decitabine; Humans; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Pancreatic Neoplasms; Promoter Regions, Genetic; Transcription Factors; Tumor Suppressor Proteins; Up-Regulation | 2017 |
Role of myofibroblasts in innate chemoresistance of pancreatic carcinoma--epigenetic downregulation of caspases.
Topics: Animals; Apoptosis; Azacitidine; Carcinoma, Pancreatic Ductal; Caspases; Cell Line, Tumor; Cell Nucleus; Coculture Techniques; Decitabine; Deoxycytidine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; Down-Regulation; Drug Resistance, Neoplasm; Epigenesis, Genetic; Etoposide; Female; Fibroblasts; Gemcitabine; Humans; Mice; Mice, SCID; Pancreatic Neoplasms; STAT1 Transcription Factor; Transfection | 2008 |
Synergistic effect of trichostatin A and 5-aza-2'-deoxycytidine on growth inhibition of pancreatic endocrine tumour cell lines: a proteomic study.
Topics: Analysis of Variance; Apoptosis; Azacitidine; Carcinoma, Pancreatic Ductal; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Decitabine; Drug Synergism; Endocrine Gland Neoplasms; Enzyme Inhibitors; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Pancreatic Neoplasms | 2009 |
Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
Topics: Adult; Aged; Aged, 80 and over; Azacitidine; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Cell Line; China; CpG Islands; Decitabine; DNA Methylation; DNA Modification Methylases; Down-Regulation; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Pancreatic Neoplasms; Prognosis; Promoter Regions, Genetic; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Tumor Suppressor Proteins | 2012 |
Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma.
Topics: Animals; Azacitidine; Carcinoma, Pancreatic Ductal; Decitabine; DNA Methylation; Female; Humans; Male; Mice; Mice, Transgenic; Pancreatic Neoplasms; Stromal Cells | 2013 |
Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas.
Topics: Acetylation; Aged; Azacitidine; Carcinoma, Pancreatic Ductal; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Female; Gene Silencing; Genes, Tumor Suppressor; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Immunoenzyme Techniques; Lymphatic Metastasis; Male; Middle Aged; Pancreatic Neoplasms; Promoter Regions, Genetic; Proteins; Serpins; Tumor Cells, Cultured; Up-Regulation | 2003 |
Proteomic analysis of pancreatic ductal carcinoma cells treated with 5-aza-2'-deoxycytidine.
Topics: Actin Depolymerizing Factors; Azacitidine; Carcinoma, Pancreatic Ductal; Cell Division; Contractile Proteins; Cyclin-Dependent Kinase Inhibitor p16; Cyclophilin A; Cystatin B; Cystatins; Decitabine; DNA Methylation; Humans; Mass Spectrometry; Microfilament Proteins; Pancreatic Neoplasms; Profilins; Promoter Regions, Genetic; Proteomics; Rosaniline Dyes; Superoxide Dismutase; Tumor Cells, Cultured | 2003 |
Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Azacitidine; Base Sequence; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Decitabine; DNA Primers; Glycoproteins; Humans; Hydroxamic Acids; Loss of Heterozygosity; Oligonucleotide Array Sequence Analysis; Pancreatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Transplantation, Heterologous | 2005 |
Abrogation of DUSP6 by hypermethylation in human pancreatic cancer.
Topics: Acetylation; Adenocarcinoma; Azacitidine; Base Sequence; Carcinoma, Pancreatic Ductal; Cell Differentiation; CpG Islands; DNA Methylation; Dual Specificity Phosphatase 6; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Gene Silencing; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Molecular Sequence Data; Neoplasm Invasiveness; Pancreatic Neoplasms; Protein Tyrosine Phosphatases; Tumor Cells, Cultured | 2005 |
Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling.
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Azacitidine; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cluster Analysis; Cyclin-Dependent Kinase Inhibitor p57; Decitabine; Down-Regulation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Immunohistochemistry; Oligonucleotide Array Sequence Analysis; Pancreatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction | 2005 |
Diagnostic utility of aberrant methylation of tissue factor pathway inhibitor 2 in pure pancreatic juice for pancreatic carcinoma.
Topics: Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Azacitidine; Carcinoma, Pancreatic Ductal; Carcinoma, Papillary; Cell Line, Tumor; DNA Methylation; DNA, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Male; Middle Aged; Pancreatic Juice; Pancreatic Neoplasms; Pancreatitis, Chronic; Polymerase Chain Reaction; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm | 2006 |